Study summary: This study aims to establish a data registry to determine the incidence of IPMN and understand their progression to pancreatic cancer.
Status: OPEN - Recruiting
Sponsor: Epworth HealthCare
Diagnosis or condition: Individuals diagnosed with Intraductal papillary mucinous neoplasms (IPMN)
  • Key inclusion criteria
    • Adults between the age of 18 and 90 years old who have been identified with a pancreatic cystic mass consistent with IPMN on radiological and/or endoscopic imaging.
  • Key exclusion criteria
    • Individuals who have been diagnosed with pancreatic cancer.

APCR

Locations: Epworth Richmond, Epworth Freemasons (East Melbourne)

Epworth PI: A/Prof Andrew Metz

Jreissati Pancreatic Centre at Epworth 

Access this Research Study

Healthcare professionals


Refer your patient

General enquiries

Please contact us for more information on 03 9426 8880 or email [email protected]


Back to all Clinical Trials and Research Studies